Skip to main content
OpenTrials
Completed

NCT Number: NCT05251623

Walking Program With Pedometer on Quality of Life in COPD

The aim of this study is to investigate the effects of a walking program on exercise capacity and quality of life in patient with COPD. Method: Patients with COPD were randomly assigned to pedometer group (PG) or control group (CON). Subjects in PG walked to target steps daily with pedometer for 6 weeks. Before and after the program, the following measurements were performed: pulmonary function test (PFT), daily steps, Six-Minute Walk Test (6MWT), COPD Assessment Test (CAT), and quality of life questionnaire (SF-12).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Obstructive Pulmonary Disease Behavior Chronic Disease Disease Attributes Lung Diseases Lung Diseases, Obstructive Motor Activity Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Taoyuan General Hospital

Taoyuan, 333, Taiwan

About this study

Patients with chronic obstructive pulmonary disease (COPD) are suffered from impaired pulmonary function and dyspnea which result to limited level of physical activity, and impaired quality of life. Exercise and regular physical activity have been proven to break the vicious circle. The aim of this study is to investigate the effects of a walking program on exercise capacity and quality of life in patient with COPD. Method: Patients with COPD were randomly assigned to pedometer group (PG) or control group (CON). Subjects in PG walked to target steps daily with pedometer for 6 weeks. Before and after the program, the pulmonary function was assessed by spiromtery test. The exercise capacity were assessed by six-minute walking test, the physical activity level was assessed by daily steps, The quality of life was assessed by COPD Assessment Test (CAT), and quality of life questionnaire (SF-12).

.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • diagnosed with COPD
  • in a medically stable condition
  • able to walk unassisted
  • ≥ 40 years of age

Exclusion criteria

  • oxygen therapy,
  • hemodynamic instability,
  • signs/symptoms of acute infection
  • severe neurological, musculoskeletal, or cardiovascular conditions that affect walking

Treatment and study plan

Walking program

Other

Subjects in PG walked to target steps daily with pedometer for 6 weeks

Primary outcomes

  1. tidal volume

    Time frame: week 0

    the amount of air that moves in or out of the lungs with each respiratory cycle. It is measured by spirometers.

  2. tidal volume

    Time frame: week 7

    the amount of air that moves in or out of the lungs with each respiratory cycle. It is measured by spirometers.

  3. Short-form 12 questionnaire (SF-12)

    Time frame: week 0

    The SF-12 is a quality of life questionnaire. The scores range from 0 (worst conceivable QOL) to 100 (best conceivable QOL)

  4. Short-form 12 questionnaire (SF-12)

    Time frame: week 7

    The SF-12 is a quality of life questionnaire. The scores range from 0 (worst conceivable QOL) to 100 (best conceivable QOL)

  5. 6 minute walking test

    Time frame: week 0

    walking distance

  6. 6 minute walking test

    Time frame: week 7

    walking distance

  7. daily steps

    Time frame: week0

    the number of total walking steps per day which is measured by pedometer.

  8. daily steps

    Time frame: week 7

    the number of total walking steps per day which is measured by pedometer.

Sponsors and collaborators

Lead sponsor

Chang Gung University

Other

Registry information

Official study title

The Effect of Walking Program With Pedometer on Quality-of-life Among Chronic Obstructive Pulmonary Disease Patients

Acronym: COPD

Important dates

Study start
2018
Primary completion
2018
Study completion
2019
First posted
Feb 23, 2022
Registry last updated
Feb 23, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.